Getein Biotech,Inc: 2023 Accounting Firm Performance Assessment Report
Getein Biotech,Inc: Special note by the board of directors on matters covered in the 2023 internal control audit report with unqualified opinions on the highlighted areas
Getein Biotech,Inc: Announcement on the implementation of daily related transactions in 2023 and the forecast for daily related transactions in 2024
Getein Biotech,Inc: Announcement of Resolutions of the Second Meeting of the Fourth Board of Directors
Getein Biotech,Inc: Announcement of Resolutions of the Second Meeting of the Fourth Board of Supervisors
Getein Biotech,Inc: Notice on changes in accounting policies
Getein Biotech,Inc: Announcement on the renewal of the 2024 annual audit accounting firm
Getein Biotech,Inc: Announcement on the Company and its wholly-owned and holding subsidiaries applying for comprehensive credit lines from banks
Getein Biotech,Inc: Announcement on holding the 2023 Annual Results Briefing
Getein Biotech,Inc: 2023 Annual Audit Report
Getein Biotech,Inc: Special explanation on the use of non-operating capital and other related financial transactions in 2023 by Geidou Biotech
Getein Biotech,Inc: 2023 Independent Director Debriefing Report (Luo Jing)
Getein Biotech,Inc: Special note by the board of directors on matters covered in the 2023 unqualified opinion audit report with highlighted sections
Getein Biotech,Inc: Board notes on changes in accounting policies
Getein Biotech,Inc: Notarized Tianye Certified Public Accountants (Special General Partnership) Special Notice on Issuing Non-standard Audit Opinions on the Company's 2023 Financial Statements
Getein Biotech,Inc: 2023 Internal Control Audit Report
Getein Biotech,Inc: Special note by the board of supervisors on matters covered in the 2023 internal control audit report with unqualified opinions on the highlighted areas
Getein Biotech,Inc: Explanation of changes in accounting policies by the Board of Supervisors
Getein Biotech,Inc: Opinions of the Board of Supervisors on the “Special Explanation of the Board of Directors on Matters Involved in the 2023 Unqualified Audit Report with Highlighted Matters”
Getein Biotech,Inc: 2023 Independent Director Debriefing Report (Wan Suiren)
No Data